Celltrion
068270.KS
#660
Rank
โ‚ฌ28.14 B
Marketcap
135,87ย โ‚ฌ
Share price
0.00%
Change (1 day)
33.21%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

Market capitalization of Celltrion (068270.KS)

Market cap: โ‚ฌ28.14 Billion

As of September 2024 Celltrion has a market cap of โ‚ฌ28.14 Billion. This makes Celltrion the world's 660th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Celltrion from 2007 to 2024

End of year Market Cap

Year Market cap Change
2024โ‚ฌ28.14 B-7.08%
2023โ‚ฌ30.28 B79.19%
2022โ‚ฌ16.90 B-17.07%
2021โ‚ฌ20.38 B-44.75%
2020โ‚ฌ36.88 B108.01%
2019โ‚ฌ17.73 B-18.21%
2018โ‚ฌ21.68 B1.06%
2017โ‚ฌ21.45 B107.57%
2016โ‚ฌ10.33 B39.6%
2015โ‚ฌ7.40 B148.84%
2014โ‚ฌ2.97 B15.22%
2013โ‚ฌ2.58 B-21.46%
2012โ‚ฌ3.28 B16.93%
2011โ‚ฌ2.81 B8.21%
2010โ‚ฌ2.59 B182.07%
2009โ‚ฌ0.92 B61.13%
2008โ‚ฌ0.57 B4411.42%
2007โ‚ฌ12.67 M

End of Day market cap according to different sources

On Sep 19th, 2024 the market cap of Celltrion was reported to be:

โ‚ฌ28.14 Billion
by Yahoo Finance info icon info icon
โ‚ฌ28.14 Billion
by CompaniesMarketCap info icon info icon